Novel Technologies

OncoCellMDx has developed technologies to compare genomic profiles of phagocytes and lymphocytes from a given subject, as a mechanism to filter out genomic sequences that are not related to the presence of perturbations due to disease that may affect gene expression. Our methodologies can thus lead to the identification and stratification of subjects with various deviations from a healthy baseline or reference state.